Moderna vaccine raises hopes, proves 94.5% effective

Moderna announced on Monday that its experimental COVID-19 vaccine 'mRNA-1273' was 94.5 per cent effective in preventing coronavirus. The statement was issued on the basis of interim data from a late-stage clinical trial. The announcement makes Moderna the second US-based pharmaceutical giant to have reported exceedingly hopeful results from clinical trials of their respective coronavirus vaccine candidates, after Pfizer vaccine. Watch the video for more.